CLINICAL_TRIALS
trial_result
· 2018-03-13
Clinical Trial Update: Mirtazapine for the Treatment of Methamphetamine Dependence Among MSM (M2.0) [Phase 2]
Summary
A Phase 2 clinical trial evaluating mirtazapine for methamphetamine use disorder has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Phillip Coffin, MD, MIA | Conditions: Amphetamine-Related Disorders | Phase 2 | Status: COMPLETED